| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.636 | 19.419 | 28.138 | 24.725 | 25.142 | 32.443 | 28.672 | 31.865 | 32.165 | 20.329 |
| Total Income - EUR | 16.636 | 19.419 | 28.138 | 24.725 | 25.142 | 33.477 | 28.672 | 31.967 | 34.187 | 20.329 |
| Total Expenses - EUR | 15.658 | 16.924 | 26.721 | 25.672 | 29.439 | 32.998 | 29.549 | 31.160 | 33.827 | 20.689 |
| Gross Profit/Loss - EUR | 978 | 2.495 | 1.417 | -947 | -4.298 | 479 | -877 | 806 | 360 | -360 |
| Net Profit/Loss - EUR | 479 | 2.107 | 1.136 | -1.194 | -4.550 | 199 | -1.122 | 21 | 18 | -733 |
| Employees | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vio Fitofarm Co Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 647 | 422 | 212 | 0 | 0 |
| Current Assets | 10.746 | 14.668 | 15.154 | 15.071 | 15.076 | 14.814 | 15.990 | 13.443 | 7.669 | 6.651 |
| Inventories | 9.472 | 13.104 | 13.741 | 13.665 | 13.522 | 12.992 | 12.118 | 11.644 | 5.894 | 724 |
| Receivables | 1.264 | 1.558 | 634 | 348 | 1.388 | 1.803 | 2.022 | 1.761 | 1.728 | 5.790 |
| Cash | 11 | 6 | 780 | 1.058 | 167 | 19 | 1.850 | 38 | 46 | 137 |
| Shareholders Funds | 7 | 7 | 7 | -1.187 | -2.140 | -1.900 | -2.980 | -2.968 | -2.941 | -3.657 |
| Social Capital | 4 | 4 | 4 | 4 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.739 | 14.661 | 15.147 | 16.258 | 17.216 | 17.361 | 19.392 | 16.622 | 10.610 | 10.308 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Vio Fitofarm Co Srl